| Literature DB >> 31729453 |
Laila Elsherif1,2, Noah Sciaky3, Carrington A Metts4, Md Modasshir5, Ioannis Rekleitis5, Christine A Burris6, Joshua A Walker4, Nadeem Ramadan4, Tina M Leisner4, Stephen P Holly7, Martis W Cowles8, Kenneth I Ataga9,10, Joshua N Cooper6, Leslie V Parise4,11,12.
Abstract
We introduce machine learning (ML) to perform classification and quantitation of images of nuclei from human blood neutrophils. Here we assessed the use of convolutional neural networks (CNNs) using free, open source software to accurately quantitate neutrophil NETosis, a recently discovered process involved in multiple human diseases. CNNs achieved >94% in performance accuracy in differentiating NETotic from non-NETotic cells and vastly facilitated dose-response analysis and screening of the NETotic response in neutrophils from patients. Using only features learned from nuclear morphology, CNNs can distinguish between NETosis and necrosis and between distinct NETosis signaling pathways, making them a precise tool for NETosis detection. Furthermore, by using CNNs and tools to determine object dispersion, we uncovered differences in NETotic nuclei clustering between major NETosis pathways that is useful in understanding NETosis signaling events. Our study also shows that neutrophils from patients with sickle cell disease were unresponsive to one of two major NETosis pathways. Thus, we demonstrate the design, performance, and implementation of ML tools for rapid quantitative and qualitative cell analysis in basic science.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31729453 PMCID: PMC6858304 DOI: 10.1038/s41598-019-53202-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(A) The first panel represents one field (672 × 512 pixels of a 16-bit image) out of 36 fields in a typical image; the inset contains nuclei with the annotations 1 or 2 corresponding to non-NETotic and NETotic nuclei, respectively. The annotations were generated manually using ImageJ. The pixel-level (PL) classifier was trained by scanning the whole image (a total of 4032 × 3072 pixels) in 32 × 32-pixel patches and classifying each patch as a class 1 or 2 using the annotations found on the image. The object-level (OL) classifier uses drawn bounding boxes of variable dimensions around all objects identified in the image and uses the object in the bounding box as training data. (B) Confusion matrices were used to evaluate model performance on the holdout dataset excluding the training dataset. The n numbers represent the holdout dataset only. The numbers in red denote model accuracy, which is the percentage of total correct predictions by the CNN. Recall is the number of true positives divided by true positive + false negative or the fraction of actual true positive predictions identified correctly. Precision is the number of true positive values divided by true positive + false positive or the fraction of positive identifications that were actually correct. An example of what would constitute true positive, true negative, false positive and false negative for class 1 is shown in matrix 3. Matrices 1 and 2 represent confusion matrices for PL and OL respectively. The nuclei images adjacent to the matrices indicate which nuclei were labeled as class 0, 1 or 2 by the two different CNN. The major difference in training of the CNNs is the class 0 category. (C) Pearson’s correlation coefficient (r) was used to compare the quantification of PL and OL (CNN prediction) to that performed manually (ground truth). A total of 186 and 161 images containing hundreds of cells were quantified by PL and OL, respectively, with a confidence interval of 95%, p < 0.0001 for all obtained R values. Each dot represents an image that was counted manually and by a CNN for the total number of Non-NETotic (graphs on the left), and NETotic cells (graphs on the right) in an image. (D) Guided backpropagation as well as gradient-weighted class activation mapping were used to generate saliency maps evaluating the relative contributions of each pixel to the CNN’s prediction. The brighter a pixel appears on this map, the more salient it is in identifying the phenotype and the more value it has in determining the CNN’s prediction.
Breakdown of the number of nuclei used for training, validation and testing the PL and OL CNNs.
| Total No. of Nuclei used for: | |||
|---|---|---|---|
| Training | Validation | Testing | |
| PL | 83099 | — | 20774 |
| OL | 65323 | 17209 | 19650 |
Figure 2(A) A CNN trained on a total of 1286 individual NETotic nuclei (807 and 479 nuclei produced as a result of PMA or A23187 treatment, respectively). Treatment time was 120 min and we analyzed images where agonist concentration would result in 50% NETotic nuclei. Nuclei were cropped out of images in a bounding box of a fixed dimension and used for CNN training. The confusion matrix demonstrates CNN’s ability to differentiate between the two nuclei with an accuracy of ~73%. The dataset used for testing (n = 428) represents 25% of the total number of images and is a subset that was excluded from the training set. An example of a PMA- and A23187-treated nucleus is shown below the matrix. (B) Necrosis was induced by freezing neutrophils at −80 °C for 80 min on tissue culture plates. Comparison between necrotic and NETotic nuclei was performed similarly to that between PMA- and A23187-induced NETotic nuclei. A total of 244 necrotic, 506 A23187-induced and 833 PMA-induced NETotic nuclei were used for training the CNN. Although the number of necrotic nuclei used for training was relatively small, the CNNs achieved exceptionally high performance accuracies in differentiating between necrotic and NETotic nuclei as is seen in matrix 1 for PMA-treatment versus necrosis and matrix 2 for A23187-treatment versus necrosis. Images below the confusion matrices demonstrate the clear difference in appearance of NETotic and necrotic nuclei. (C) PMA was used to induce ROS-dependent NETosis and EC50 values were calculated as described in Methods. The percentage of DMSO in the highest agonist concentration was used as the vehicle control. EC50 was determined to be 2.1 nM for PMA and the 95% CI interval = 0.5–6.8, (n = 11). The 95% confidence bands are the dashed lines on the plot. (D) A23187 was used to induce PAD4-dependent NETosis and EC50 was determined to be 930 nM for A23187 with a 95% CI interval of 0.6–1.3, (n = 8). The percentage of DMSO in the highest agonist concentration was used as the vehicle control. The 95% confidence bands are the dashed lines on the plot. (E) DMSO is a widely used solvent for many NETosis agonists and inhibitors and we show that it acts as a NETosis agonist, reaching a maximum response of 30% at 0.16% DMSO (n = 3–5 data points for each concentration used), 95% CI for EC50 = 0.003–0.085. The dash lines represent 95% confidence bands. (F) Dispersion and clustering of NETotic nuclei differs depending on the type of treatment as can be seen in the images (right panels). CNNs were used to calculate and compare the clustering characteristics using Average Nearest Neighbor Distances which reveal significant differences (p ≤ 0.025) between PMA and A23187 treatments. Images chosen for analysis were those containing similar numbers of NETotic nuclei. The two sets of ANND values were compared using Kolmogorov-Smirnov test, which was run 10 times to obtain the following p-values: 0.0000022, 0.018, 0.0050, 0.00082, 0.0048, 0.000046, 0.025, 0.000077, 0.016, 0.0063. The average p-value is 0.0076. (G) The same cell isolation and agonist conditions were used to treat neutrophils from patients with SCD at steady-state (squares, dashed lines, n = 7) and non-SCD (circles, solid line, n = 11). The number of nuclei analyzed following PMA treatment is 752,824 and 410,238 for non-SCD and SCD groups respectively. Following A23187 treatment the number of nuclei analyzed was 314,037 and 94,759 for non-SCD and SCD groups respectively. Neutrophils from patients with SCD responded poorly to PMA treatment (two-way ANOVA, p < 0.05) suggesting impairment in the ROS-dependent NETotic pathway (graph on the left); in contrast no significant difference was observed between SCD and non-SCD donors in response to A23187 treatment (graph on the right), suggesting that PAD4-mediated NETosis is unimpaired in SCD.